东北制药
(000597)
| 流通市值：72.57亿 | | | 总市值：73.50亿 |
| 流通股本：14.09亿 | | | 总股本：14.27亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,385,711,552.83 | 4,468,332,416.81 | 5,077,551,429.32 | 4,892,107,187.47 |
| 应收票据及应收账款 | 2,882,722,883.73 | 2,493,652,177.21 | 2,631,650,665.6 | 2,801,476,279.53 |
| 其中：应收票据 | 488,221,659.59 | 534,622,306.52 | 524,745,290.13 | 531,049,967.79 |
| 应收账款 | 2,394,501,224.14 | 1,959,029,870.69 | 2,106,905,375.47 | 2,270,426,311.74 |
| 预付款项 | 100,978,445.88 | 140,839,635.54 | 91,066,557.23 | 51,244,978.86 |
| 其他应收款合计 | 225,625,551.61 | 192,507,181.41 | 286,850,290 | 238,693,407.81 |
| 其中:应收利息 | - | 0 | - | - |
| 应收股利 | - | 0 | - | - |
| 存货 | 1,310,723,643.91 | 1,323,826,723.69 | 1,272,892,511.17 | 1,404,346,807.26 |
| 合同资产 | 710,329.75 | 807,489.23 | 8,049,808.29 | 6,799,785.52 |
| 其他流动资产 | 34,683,766.34 | 26,520,171.69 | 37,125,258.05 | 34,322,136.69 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 7,941,156,174.05 | 8,646,485,795.58 | 9,405,186,519.66 | 9,428,990,583.14 |
| 非流动资产: | | | | |
| 长期股权投资 | 6,127,595.39 | 6,127,595.39 | - | - |
| 固定资产 | 3,743,105,909.26 | 3,853,775,267.88 | 3,857,919,427.85 | 3,977,320,947.64 |
| 在建工程 | 152,846,320.34 | 155,476,187.39 | 210,538,173.92 | 240,439,766.35 |
| 使用权资产 | 51,384,144.13 | 54,642,267.12 | 39,370,423.13 | 42,442,020.8 |
| 无形资产 | 673,682,842.8 | 687,831,364.73 | 661,224,207.78 | 662,259,692.39 |
| 开发支出 | 721,892,430.68 | 717,739,470.7 | 140,138,131.24 | 145,759,695.38 |
| 商誉 | 154,102,928.32 | 154,447,077.24 | 26,118,604.81 | 26,118,604.81 |
| 长期待摊费用 | 22,314,194.67 | 24,311,985.86 | 744,659.79 | 606,302.26 |
| 递延所得税资产 | 131,912,110.1 | 131,378,508.69 | 127,741,624.42 | 118,434,762.51 |
| 其他非流动资产 | 12,669,321.12 | 13,966,330.67 | 28,091,436.71 | 27,331,136.23 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 5,670,037,796.81 | 5,799,696,055.67 | 5,091,886,689.65 | 5,240,712,928.37 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 13,611,193,970.86 | 14,446,181,851.25 | 14,497,073,209.31 | 14,669,703,511.51 |
| 流动负债: | | | | |
| 短期借款 | 1,967,000,000 | 1,542,200,000 | 1,482,200,000 | 1,577,200,000 |
| 应付票据及应付账款 | 3,578,315,191.13 | 4,840,518,043.29 | 5,019,626,916.02 | 5,032,655,567.46 |
| 其中：应付票据 | 2,054,666,059.86 | 3,536,592,539.37 | 3,679,496,265.44 | 3,434,837,873.48 |
| 应付账款 | 1,523,649,131.27 | 1,303,925,503.92 | 1,340,130,650.58 | 1,597,817,693.98 |
| 合同负债 | 79,416,507.1 | 104,806,624.47 | 85,340,999.38 | 69,663,250.63 |
| 应付职工薪酬 | 2,620,157.61 | 46,252,665.34 | 2,035,150.81 | 4,214,306.73 |
| 应交税费 | 54,970,982.33 | 79,952,928.07 | 59,011,826.09 | 82,950,379.76 |
| 其他应付款合计 | 1,639,132,684.24 | 1,577,265,049.42 | 1,494,050,366.01 | 1,607,893,244.92 |
| 其中:应付利息 | - | 0 | 1,572,237.34 | 750,386 |
| 应付股利 | 1,597,979.18 | 1,597,979.18 | 1,597,979.18 | 1,597,979.18 |
| 一年内到期的非流动负债 | 58,828,607.12 | 55,428,853.85 | 641,729,690.41 | 643,931,645.22 |
| 其他流动负债 | 5,992,493.41 | 10,499,746.51 | 8,995,300.82 | 6,957,193.48 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 7,386,276,622.94 | 8,256,923,910.95 | 8,792,990,249.54 | 9,025,465,588.2 |
| 非流动负债: | | | | |
| 长期借款 | 78,400,000 | - | - | 78,400,000 |
| 租赁负债 | 27,465,713.26 | 30,137,899.3 | 17,598,917.91 | 19,291,597.26 |
| 递延收益 | 137,104,805.17 | 140,905,277.36 | 144,875,730.85 | 148,911,071.12 |
| 递延所得税负债 | 95,177,598.11 | 95,742,193.5 | 3,170,418.01 | 3,305,058.36 |
| 其他非流动负债 | 281,858,336.09 | 352,829,670.57 | 185,200,000 | 185,200,000 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 620,006,452.63 | 619,615,040.73 | 350,845,066.77 | 435,107,726.74 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 8,006,283,075.57 | 8,876,538,951.68 | 9,143,835,316.31 | 9,460,573,314.94 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,429,103,265 | 1,429,103,265 | 1,429,103,265 | 1,429,103,265 |
| 资本公积 | 2,490,048,047.37 | 2,490,048,047.37 | 2,495,269,947.39 | 2,493,981,247.38 |
| 减:库存股 | 67,129,260 | 67,129,260 | 20,329,260 | 110,717,740 |
| 其他综合收益 | 2,524,180.9 | 2,582,921.95 | 1,496,987.17 | 2,190,307.11 |
| 专项储备 | 6,342,561.96 | 6,387,512.2 | 6,442,400.43 | 6,435,101.26 |
| 盈余公积 | 192,624,557.66 | 192,624,557.66 | 180,321,681.95 | 180,321,681.95 |
| 未分配利润 | 1,304,317,482.67 | 1,267,995,910.44 | 1,078,418,846.18 | 1,027,259,787.73 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,357,830,835.56 | 5,321,612,954.62 | 5,170,723,868.12 | 5,028,573,650.43 |
| 少数股东权益 | 247,080,059.73 | 248,029,944.95 | 182,514,024.88 | 180,556,546.14 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,604,910,895.29 | 5,569,642,899.57 | 5,353,237,893 | 5,209,130,196.57 |
| 负债和股东权益合计 | 13,611,193,970.86 | 14,446,181,851.25 | 14,497,073,209.31 | 14,669,703,511.51 |
| 公告日期 | 2025-04-29 | 2025-04-03 | 2024-10-24 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |